StockData
Structure Therapeutics Inc. logo

Structure Therapeutics Inc. (GPCR) stock

GPCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$17.36−0.81 (-4.46%)

Close on Nov 18, 2026Market cap $1.24BP/E –Yield –

Structure Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Structure Therapeutics's market cap was $1.49B on Nov 11, 2026, against $2.17B a year earlier. Over the last 4 years it ranged from $83.48M to $5.37B, with a median of $1.61B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.49B-64.6%
2025Dec 31, 2025$4.22B+171.8%
2024Dec 31, 2024$1.55B+46.8%
2023Dec 29, 2023$1.06B–

More Structure Therapeutics figures

See a number that looks wrong?